J&J to buy J B Chemicals’ Russian OTC drugs for $260 million

24 May 2011

1

Johnson & Johnson is acquiring several over-the-counter medicines sold in Russia from India's J B Chemicals and Pharmaceuticals Ltd, for about $260 million as part of its strategy of expanding into other emerging markets.

The brands included in the acquisition are Rinza, Russia's leading multi-symptom cough and cold brand, and Doktor Mom, Russia's number two selling cough brand, as well as several other brands.

The acquisition is being carried through Cilag GmbH International, a wholly-owned subsidiary of J&J.

J&J and its affiliates will market these products in Russia, the world's eighth largest OTC market, and in the Commonwealth of Independent States and other countries. 

The OTC market in Central & Eastern European countries grew 8-9 per cent to €10 billion ($15 billion) in 2009, with Russia holding a 50 per cent market share, according to an HDFC Securities report.

"Emerging markets continue to be an important growth opportunity for Johnson & Johnson," said Jesse Wu, worldwide chairman, Johnson & Johnson Group of Consumer Companies. "This acquisition of strong brands in Russia will allow us to expand our OTC offerings in these growth markets and support our emerging markets strategy."

Business History Videos

History of hovercraft Part 3...

Today I shall talk a bit more about the military plans for ...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of hovercraft Part 2...

In this episode of our history of hovercraft, we shall exam...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Hovercraft Part 1...

If you’ve been a James Bond movie fan, you may recall seein...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Trams in India | ...

The video I am presenting to you is based on a script writt...

By Aniket Gupta | Presenter: Sheetal Gaikwad

view more